<DOC>
	<DOCNO>NCT00192777</DOCNO>
	<brief_summary>Hypothesis : Radiosensitization use Xeloda improve rate complete pain relief . Primary Objective : - To determine frequency pain relief propose regimen . Secondary Objective ( ) : - To determine duration pain relief narcotic relief propose regimen . - To determine frequency narcotic relief propose regimen . - To determine toxicity concurrent UFT radiotherapy patient bone metastasis .</brief_summary>
	<brief_title>Concurrent Xeloda Radiotherapy Bone Metastases</brief_title>
	<detailed_description />
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Neoplasms , Second Primary</mesh_term>
	<mesh_term>Bone Neoplasms</mesh_term>
	<mesh_term>Bone Marrow Diseases</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<criteria>1 . The patient must 18 year age old . 2 . The patient must epithelial malignancy . 3 . Radiographic evidence bone metastasis require . Acceptable study include plain radiograph , radionuclide bone scan , compute tomography scan magnetic resonance imaging . 4 . The patient must pain appear relate radiographically document metastasis . 5 . Patients must estimate life expectancy 3 month great . 6 . Signed studyspecific inform consent . 7 . Karnofsky performance status ï‚³ 40 . 8 . Calculated creatinine clearance &gt; 50 ml/min</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>Solid Tumors</keyword>
	<keyword>Bone Metastases</keyword>
	<keyword>Radiotherapy</keyword>
	<keyword>Xeloda</keyword>
	<keyword>Concurrent</keyword>
	<keyword>Radiosensitization</keyword>
</DOC>